🇺🇸 FDA
Pipeline program

glatiramer acetate injection with oral cetirizine hydrochloride

PM014

Approved small_molecule completed

Quick answer

glatiramer acetate injection with oral cetirizine hydrochloride for Multiple Sclerosis is a Approved program (small_molecule) at Teva Pharma GmbH with 1 ClinicalTrials.gov record(s).

Program details

Company
Teva Pharma GmbH
Indication
Multiple Sclerosis
Phase
Approved
Modality
small_molecule
Status
completed

Clinical trials